Financhill
Sell
27

CRBP Quote, Financials, Valuation and Earnings

Last price:
$11.92
Seasonality move :
77.59%
Day range:
$11.85 - $13.20
52-week range:
$6.63 - $61.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
69.29x
P/B ratio:
0.96x
Volume:
186K
Avg. volume:
279.4K
1-year change:
93.82%
Market cap:
$145.2M
Revenue:
--
EPS (TTM):
-$4.67

Earnings Data

Next earnings date for CRBP
Mar 12
2025
Most recent earnings per share
-$1.15
Missed by $0.20
(Nov 7/2024)
Consensus Estimate
-$0.95
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRBP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$1.51 --
03/12/2025 Q4 -- -- -- -$1.26 --
11/07/2024 Q3 -- -- -$1.15 -$0.95 -$0.20
08/06/2024 Q2 -- -- -$0.90 -$1.19 $0.29
05/07/2024 Q1 -- -- -$0.83 -$1.09 $0.26
03/12/2024 Q4 -- -- -$1.79 -$2.36 $0.57
11/07/2023 Q3 -- -- -$2.27 -$2.06 -$0.21
08/08/2023 Q2 -- -- -$2.05 -$3.10 $1.05
05/09/2023 Q1 -- -- -$4.24 -$4.09 -$0.15
03/08/2023 Q4 -- -- -$2.61 -$2.10 -$0.51
11/11/2022 Q3 -- -- -$2.11 -$1.65 -$0.46
08/09/2022 Q2 -- -- -$3.18 -$1.80 -$1.38
05/10/2022 Q1 -- -- -$2.26 -- --
03/08/2022 Q4 -- -- -$2.40 -- --
11/12/2021 Q3 -- -- -$0.60 -- --
08/12/2021 Q2 -- -- -$4.50 -- --
05/13/2021 Q1 -- -- -$4.20 -- --
03/15/2021 Q4 -- -- -$3.00 -- --
11/10/2020 Q3 -- -- -$12.90 -- --
08/06/2020 Q2 -- -- -$15.60 -- --
05/11/2020 Q1 -- -- -$12.90 -- --
03/12/2020 Q4 -- -- -$12.30 -- --
11/07/2019 Q3 -- -- -$9.60 -- --
08/08/2019 Q2 -- -- $0.90 -- --
05/09/2019 Q1 -- -- -$12.90 -- --
03/12/2019 Q4 -- -- -$9.00 -- --
11/08/2018 Q3 -- -- -$7.80 -- --
08/08/2018 Q2 -- -- -$6.30 -- --
05/10/2018 Q1 -- -- -$6.30 -- --
03/12/2018 Q4 -- -- -$6.30 -- --
11/08/2017 Q3 -- -- -$4.20 -- --
08/09/2017 Q2 -- -- -$4.50 -- --
03/31/2017 Q1 -- -- -$4.80 -- --
12/31/2016 Q4 -- -- -$5.40 -- --
11/10/2016 Q3 -- -- -$3.60 -- --
08/15/2016 Q2 -- -- -$3.30 -- --
03/31/2016 Q1 -- -- -$2.40 -- --
12/31/2015 Q4 -- -- -$1.80 -- --
09/30/2015 Q3 -- -- -$1.80 -- --
06/30/2015 Q2 -- -- -$3.00 -- --
03/31/2015 Q1 -- -- -$1.80 -- --

Corbus Pharmaceuticals Holdings Earnings Questions

  • How Much did Corbus Pharmaceuticals Holdings Generate in Revenue Last Quarter?

    Corbus Pharmaceuticals Holdings reported -- worth of top line sales in its most recent quarter.

  • Did Corbus Pharmaceuticals Holdings Beat Earnings Last Quarter?

    Corbus Pharmaceuticals Holdings announced earnings per share of -$1.15 which represents a miss of analyst forecast a -$0.95 per share.

  • Is Corbus Pharmaceuticals Holdings Profitable?

    Corbus Pharmaceuticals Holdings reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Corbus Pharmaceuticals Holdings EPS Next Year?

    Corbus Pharmaceuticals Holdings's earnings are forecast to decrease from -$10.31 per share to -$4.38 per share next year representing a decrease of -57.52%.

  • When is Corbus Pharmaceuticals Holdings's Earnings Date?

    Corbus Pharmaceuticals Holdings's next earnings date is March 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is AT&T Stock Dropping?
Why Is AT&T Stock Dropping?

The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…

Is American Express Stock Going Lower?
Is American Express Stock Going Lower?

American Express Company (NYSE:AXP) has long been a Buffett favorite…

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 18

Quantum [QMCO] is down 15.61% over the past day.

Buy
51
QRVO alert for Jan 18

Qorvo [QRVO] is up 14.47% over the past day.

Sell
31
ATEX alert for Jan 18

Anterix [ATEX] is up 11.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock